Special NoticePosted Jul 21, 2026·Responses due Jul 28, 2026

Notice of Intent to Sole Source � University of Maryland Medical Center

National Institutes of Health · NATIONAL INSTITUTES OF HEALTH - CC

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
541714
Value
Not stated
Solicitation
26-007059
Set-aside
No Set aside used
PSC
6515
Place
MD, USA
Contact
Kristin Nagashima (kristin.nagashima@nih.gov)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 26-007059 in this department, oldest first.

Early notice
  • Jul 21, 2026 · this notice
    Special Notice
Solicitation
None posted
Award
Not yet. Typical award: Aug 30, 2026 to May 22, 2027, middle of the range Sep 23, 2026.
Measured from 68 past early notices at National Institutes of Health that later posted an award (middle half of cases, counted from Jul 21, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

The National Institutes of Health (NIH) Clinical Center (CC) seeks a contract with University of Maryland Medical Center at Baltimore (UMB) to provide the patient population to develop a biorepository of patients suspected of or diagnosed with pulmonary hypertension (PH). The objective is to collect blood samples, demographics, clinical assessments, and outcome data in enrolled subjects. These samples will allow us to do translational research across all the World Symposium on PH groups. � Product Service Code: 5417 � Scientific Research and Development Services � NAICS Code: 541714 � Research… (show all)

and Development in Biotechnology � Place of Performance: Bethesda, MD 20892 USA POTS: 26-007059 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to the University of Maryland Medical Center, LLC, located at 250 West Pratt St, 24th Floor, Baltimore, MD 21201, on a firm fixed price sole source award basis to provide the required biorepository of patients to the National Institutes of Health. Funding for the research to be completed with the patient samples obtained through this contract is from the 2026 Research Award for Staff Clinicians (RASCL) Award to the NIH program. For the initial studies, a local PH center of excellence is required that has an institution affiliation with the IC. Thus, in order to maintain the integrity of the research plan and adhere to the proposed work that received funding, competition will be limited for this project. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 � Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by July 28, 2026 at 3pm EST.

Who won similar work

15 award notices on SAM.gov in the last 24 months. Match: Same agency (National Institutes of Health), same NAICS 541714.

WinnerAwardsValueLast
UNIVERSITY OF MARYLAND, BALTIMORE Baltimore MD 21201 USA2$30.8MAug 6, 2026
FISHER BIOSERVICES INC · $TMO1$100.0MJan 21, 2025
Coriell Institute for Medical Research, Inc.1$48.3MAug 1, 2025
THE MCLEAN HOSPITAL CORPORATION1$34.9MNov 21, 2025
UNIVERSITY OF MIAMI Coral Gables FL 33146 USA1$26.6MNov 21, 2025
LA JOLLA INSTITUTE FOR IMMUNOLOGY La Jolla CA 92037 USA1$24.3MMar 16, 2026
UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION Pittsburgh PA 15260 USA1$19.9MNov 21, 2025
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI New York NY 10029 USA1$18.5MNov 21, 2025
Greater Los Angeles Veterans Research and Education Foundation Los Angeles CA 90073 USA1$17.7MNov 21, 2025
THE BROAD INSTITUTE, INC1$215KSep 29, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 1 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (7 filings)
  • 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
  • $64K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 8 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 1 of the past winners are listed companies
  • 0 insider buys and 7 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.